Lukashenko instructed to establish production of Russian vaccine against COVID-19 in Belarus
President of Belarus Alexander Lukashenko instructed to study the possibility of producing a Russian vaccine against coronavirus in Belarus. He instructed his assistant Aleksandr Kosinets to deal with this issue “without noise and dust”: “Sit down and think, look at similar productions and suggest”.
President of Belarus Alexander Lukashenko instructed to study the possibility of producing a Russian vaccine against coronavirus in Belarus. BelTA informs about it.
“I spoke with the President of Russia [Vladimir Putin] yesterday - there are very serious concerns there. He himself suggested: "If you have a desire, we can give you the starting material for the vaccine. Please expand production, we will do everything. Produce the vaccine for yourself, if you want to sell, sell." If we are satisfied with the Russian vaccine, study the issue and urgently make proposals on the organization of production. We need to see how much it will cost, ”Alexander Lukashenko said.
He instructed his assistant Alexander Kosinets to deal with this issue “without noise and dust”: “Sit down and think, look at similar productions and suggest. You know better than me that this is not an easy production and it is not cheap. Nobody gives their production to anyone. The President of Russia proposed this on a friendly basis. "
On November 4, Lukashenko proposed to Putin to organize the production of a vaccine against COVID-19 in Belarus. “This proposal of the Belarusian leader was supported by his Russian counterpart,” the official statement of the press service of the president of the republic said.
The world's first Russian vaccine against coronavirus was developed by the Gamaleya Center, Putin announced its registration on August 11, production began on August 15. Defense Minister Sergei Shoigu and Moscow Mayor Sergei Sobyanin have already been vaccinated.
The second Russian vaccine against COVID-19, EpiVacCorona, is produced by the Vector Center. Its clinical trials ended on September 30, and on October 14, the Russian leader announced its registration. The production of the drug began on October 27.
The Chumakov Center is developing the third vaccine against coronavirus. It is whole-virion, it uses either weakened or killed viruses that are unable to cause infectious diseases.